Scientists have long noted that people suffering from Parkinsons disease commonly exhibit a specific personality type characterized by, among other things, a lower-than-average tendency to seek out new experiences. In explanation, investigators suggested that this trait was rooted in an inability to reap the pleasurable rewards of increased dopamine levels normally brought about by new stimuli because the disease destroys the neurotransmitter. Previous studies of personality and dopamine activity in Parkinsons patients involved subjects receiving treatment for their disease. Now, for the first time, scientists have examined the link between personality and Parkinsons in patients yet to receive medication. The report, published in the current issue of the Proceedings of the National Academy of Sciences indicates that, in fact, dopamine is not involved in regulating the low-novelty-seeking trait associated with Parkinsons.
Valtteri Kaasinen of the University of Turku in Finland and colleagues studied 61 patients who had been diagnosed with Parkinsons within the past five years but were not taking medication and compared them to a control group of 45 healthy subjects. Using personality questionnaires, the scientists compared traits such as novelty seeking and harm avoidance between the two groups. Unlike previously reported studies involving medicated patients, the correlation between low novelty seeking and Parkinsons was not highly significant. The authors suggest the previously demonstrated link may have been due in part to the medication administered to treat the disease. Parkinsons patients did, however, score significantly higher than control subjects for the harm avoidance personality trait, often associated with anxiety and depression. But the authors note that this trait is not disease-specific and "possibly reflects a psychological response to a chronic disease."
The team next investigated the explicit role of dopamine in mediating the personality of a Parkinsons patient. Using positron emission tomography (PET), the scientists studied the uptake of radioactively labeled L-DOPA (a precursor to dopamine) in the brains of 47 of the Parkinsons patients. Participants with high scores for harm avoidance demonstrated increased uptake of L-DOPA in the brains right caudate region. But patients with low scores for novelty seeking did not show a similar reaction to L-DOPA. "Although the results of this study are not in disagreement with the concept of low-novelty-seeking personality type in Parkinsons disease," the authors conclude, "the personality type does not seem to be dopamine dependent."
Sarah Graham | Scientific American
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences